These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 24076432)
1. Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis. Thakur AK; Bimal S; Singh SK; Gupta AK; Das VN; Das P; Narayan S Exp Parasitol; 2013 Nov; 135(3):595-8. PubMed ID: 24076432 [TBL] [Abstract][Full Text] [Related]
2. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394 [TBL] [Abstract][Full Text] [Related]
3. Studies on stibanate resistant Leishmania donovani isolates of Indian origin. Pal S; Mandal A; Duttagupta S Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284 [TBL] [Abstract][Full Text] [Related]
4. Heme carrier protein (HCP-1) spatially interacts with the CD163 hemoglobin uptake pathway and is a target of inflammatory macrophage activation. Schaer CA; Vallelian F; Imhof A; Schoedon G; Schaer DJ J Leukoc Biol; 2008 Feb; 83(2):325-33. PubMed ID: 17947394 [TBL] [Abstract][Full Text] [Related]
5. Toll like receptor 2 and CC chemokine receptor 5 cluster in the lipid raft enhances the susceptibility of Leishmania donovani infection in macrophages. Majumdar SB; Bhattacharya P; Bhattacharjee S; Majumder S; Banerjee S; Majumdar S Indian J Exp Biol; 2014 Jan; 52(1):17-29. PubMed ID: 24617012 [TBL] [Abstract][Full Text] [Related]
6. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis. Subba Raju BV; Singh R; Sreenivas G; Singh S; Salotra P Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024 [TBL] [Abstract][Full Text] [Related]
7. Possible role of the 34-kilodalton hyaluronic acid-binding protein in visceral Leishmaniasis. Rao CM; Salotra P; Datta K J Parasitol; 1999 Aug; 85(4):682-7. PubMed ID: 10461949 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol: a potential therapeutic target in Leishmania infection? Pucadyil TJ; Chattopadhyay A Trends Parasitol; 2007 Feb; 23(2):49-53. PubMed ID: 17185038 [TBL] [Abstract][Full Text] [Related]
9. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy. Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449 [TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477 [TBL] [Abstract][Full Text] [Related]
11. CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function. Abraham NG; Drummond G Circ Res; 2006 Oct; 99(9):911-4. PubMed ID: 17068296 [No Abstract] [Full Text] [Related]
12. Iron trafficking in patients with Indian Post kala-azar dermal leishmaniasis. Dighal A; Mukhopadhyay D; Sengupta R; Moulik S; Mukherjee S; Roy S; Chaudhuri SJ; Das NK; Chatterjee M PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007991. PubMed ID: 32023254 [TBL] [Abstract][Full Text] [Related]
13. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR. Manna M; Majumder HK; Sundar S; Bhaduri AN Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683 [TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection. Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024 [TBL] [Abstract][Full Text] [Related]
15. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. Karp CL; Turco SJ; Sacks DL J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901 [TBL] [Abstract][Full Text] [Related]
16. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar. Salotra P; Raina A; Negi NS Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370 [TBL] [Abstract][Full Text] [Related]
17. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera. Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753 [TBL] [Abstract][Full Text] [Related]
18. Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases: an experimental evidence. Gupta AK; Narayan S; Verma N; Thakur AK; Das P J Vector Borne Dis; 2012 Dec; 49(4):266-7. PubMed ID: 23428529 [No Abstract] [Full Text] [Related]
19. Lymphadenopathy in a child with Indian kala-azar in Dharan, Nepal. Singh K; Singh R; Parija SC Indian Pediatr; 1998 Nov; 35(11):1125-6. PubMed ID: 10216552 [No Abstract] [Full Text] [Related]
20. Visceral leishmaniasis in the New World & Africa. Berman J Indian J Med Res; 2006 Mar; 123(3):289-94. PubMed ID: 16778311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]